蒋雄京

• 1:中国医学科学院阜外心血管病医院高血压诊治中心

摘要(Abstract)：

<正>近年来,经皮经导管射频消融去肾交感神经术(renal denervation,RDN)(以下简称"该技术")治疗难治性、顽固性高血压的临床研究在国际上相继开展,国内部分医疗单位也采用该技术陆续开展了相关的研究工作。但因该技术为一种新的有创治疗法,临床研究时间尚短,还缺乏长期疗效和安全性资料,国内外学者对其可否进入临床应用的认识存在不同程度的分歧[1]。为规范国内开展RDN治

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 蒋雄京

参考文献(References)：

• [1]Calhoun DA,Jones D,Textor S,et al.Resistant hypertension:diagnosis,evaluation and treatment.A scientific statement from the American Heart Association professional education committee of the council for high blood pressure research[J].Hypertension,2008,51(6):1403-1419.
• [2]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-743.
• [3]Salles GF,Cardoso CR,Muxfeldt ES.Prognostic influence of office and ambulatory blood pressures in resistant hypertension[J].Arch Intern Med,2008,168(21):2340-2346.
• [4]Acelajado MC,Pisoni R,Dudenbostel T,et al.Refractory hypertension:definition,prevalence,and patient characteristic[J].J Clin Hypertens(Greenwich),2012,14(1):7-12.
• [5]Smith PA,Graham LN,Mackintosh AF,et al.Relationship between central sympathetic activity and stages of human hypertension[J].Am J Hypertens,2004,17(3):217-222.
• [6]Benjelloun H,Aboudrar S,Jroundi I,et al.Sympathetic response in primary hypertension[J].Ann Cardiol Angeiol(Paris),2009,58(3):139-143.
• [7]Morrissey DM,Brookes VS,Cooke WT.Sympathectomy in the treatment of hypertension;review of 122 cases[J].Lancet,1953,1(6757):403-408.
• [8]Smithwick RH,Thompson JE.Splanchnicectomy for essential hypertension;results in 1266 cases[J].J Am Med Assoc,1953,152(16):1501-1504.
• [9]Sobotka PA,Mahfoud F,Schlaich MP,et al.Sympathorenal axis in chronic disease[J].Clin Res Cardiol,2011,100(12):1049-1057.
• [10]Krum H,Schlaich M,Whitbourn R,et al.Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study[J].Lancet,2009,373(9671):1275-1281.
• [11]Schlaich MP,Sobotka PA,Krum H.et al.Renal sympatheticnerve ablation for uncontrolled hypertension[J].N Engl J Med,2009,361(9):932-934.
• [12]Symplicity HTN-1 investigators.Catheter-based renal sympathetic denervation for resistant hyptersion:durability of blood pressure reduction out to 24 months[J].Hypertension,2011,57(5):911-917.
• [13]Symplicity HTN-2 Investigators,Esler MD,Krum H,et al.Renal sympathetic denervation in patients with treatmentresistant hypertension(the Symplicity HTN-2 Trial):a randomised controlled trial[J].Lancet,2010,376(9756):1903-1909.
• [14]Mahfoud F,Schlaich M,Kindermann I,et al.Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension:a pilot study[J].Circulation,2011,123(18):1940-1946.
• [15]Schlaich MP,Straznicky N,Grima M,et al.Renal denervation:a potential new treatment modality for polycystic ovary syndrome?[J].J Hypertens,2011,29(5):991-996.
• [16]Adam W,Aleksander P,Elzbieta F,et al.Effects of renal sympathetic denervation on blood pressure,sleep apnea course,and glycemic control in patients with resistant hypertension and sleep apnea[J].Hypertension,2011,58(4):559-565.
• [17]Ukena C,Bauer A,Mahfoud F,et al.Renal sympathetic denervation for treatment of electrical storm:first-in-man experience[J].Clin Res Cardiol,2012,101(1):63-67.
• [18]Prochnau D,Lauten A,Busch M,et al.Catheter-based radiofrequency ablation therapy of the renal sympathetic-nerve system for drug resistant hypertension in a patient with endstage renal disease[J].Int J Cardiol,2012,154(2):e29-e30.
• [19]Ukena C,Mahfoud F,Kindermann I,et al.Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension[J].J Am Coll Cardiol,2011,58(11):1176-1182.